Your agencies’ refusal to provide complete and unredacted responses and documents to my numerous oversight letters on the ...

The latest health news highlights BridgeBio's new heart drug approved by the FDA, novel findings in breast cell research, ...

BridgeBio Pharma (BBIO) wins FDA nod Attruby for rare heart disorder, ATTR-CM challenging Pfizer's (PFE) Vyndaqel. Read more ...

The U.S. Food and Drug Administration has approved BridgeBio's drug for a rare and deadly heart condition, the company said ...

Political fears and a failed clinical trial have soured the market on AbbVie. The market is still punishing Pfizer for its ...

Anthropic announced it received an additional $4 billion investment from Amazon as they deepened their partnership with AWS ...

Anthropic, one of the world’s top providers of advanced AI models, has announced a massive $4 billion investment from Amazon, ...

A COVID-19 study in Britain looked at the medical records of 1.7 million children but did not conclude the same number of ...

In today's biotech news, Prime Editing's CEO promises aggressive defense of patents; Novartis acquires a gene editing startup ...

Fewer than 18% of U.S. adults have opted to receive the newly updated COVID-19 vaccine, according to the latest data from the ...

Pfizer shares are trading lower by 10% in November. President-elect Donald Trump last week announced his intention to nominate Robert F. Kennedy Jr. to lead the HHS.